Diabetes following acute pancreatitis

Phil A. Hart; David Bradley; Darwin L. Conwell; Kathleen Dungan; Somashekar G. Krishna; Kathleen Wyne; Melena D. Bellin; Dhiraj Yadav; Dana K. Andersen; Jose Serrano; Georgios I. Papachristou

doi:10.1016/S2468-1253(21)00019-4

Diabetes following acute pancreatitis

Phil A. Hart, David Bradley, Darwin L. Conwell, Kathleen Dungan, Somashekar G. Krishna, Kathleen Wyne, Melena D. Bellin, Dhiraj Yadav, Dana K. Andersen, Jose Serrano, Georgios I. Papachristou

Pediatrics - Endocrine and Diabetes

Research output: Contribution to journal › Review article › peer-review

30 Scopus citations

Abstract

Diabetes represents a group of diseases involving persistent hyperglycaemia. Exocrine disorders of the pancreas are increasingly recognised to cause or precede the onset of diabetes, which in this context is referred to as pancreatogenic or type 3c diabetes. Diabetes, as a sequela of acute pancreatitis, is observed across the spectrum of severity in acute pancreatitis and can be associated with other clinical complications. The pathophysiology of acute pancreatitis-related diabetes is poorly understood, and observations suggest that it is probably multifactorial. In this Review, we discuss the epidemiology, pathophysiology, and management considerations of diabetes following acute pancreatitis, and highlight knowledge gaps in this topic.

Original language	English (US)
Pages (from-to)	668-675
Number of pages	8
Journal	The Lancet Gastroenterology and Hepatology
Volume	6
Issue number	8
DOIs	https://doi.org/10.1016/S2468-1253(21)00019-4
State	Published - Aug 2021

Bibliographical note

Funding Information:
Research reported in this publication was supported by the National Cancer Institute and National Institute of Diabetes and Digestive and Kidney Diseases under award numbers U01DK127388 (PAH, DB, DLC, KD, GIP), U01DK108327 (PAH, DB, DLC), U01DK126300 (MDB), U01DK127367 (MDB), U01DK108306 (DY), and U01DK127377 (DY). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Publisher Copyright:
© 2021 Elsevier Ltd

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/S2468-1253(21)00019-4

OpenUrl availability

Full text

Cite this

@article{df9be6f4ae964ff783b1262bf61b528a,

title = "Diabetes following acute pancreatitis",

abstract = "Diabetes represents a group of diseases involving persistent hyperglycaemia. Exocrine disorders of the pancreas are increasingly recognised to cause or precede the onset of diabetes, which in this context is referred to as pancreatogenic or type 3c diabetes. Diabetes, as a sequela of acute pancreatitis, is observed across the spectrum of severity in acute pancreatitis and can be associated with other clinical complications. The pathophysiology of acute pancreatitis-related diabetes is poorly understood, and observations suggest that it is probably multifactorial. In this Review, we discuss the epidemiology, pathophysiology, and management considerations of diabetes following acute pancreatitis, and highlight knowledge gaps in this topic.",

author = "Hart, {Phil A.} and David Bradley and Conwell, {Darwin L.} and Kathleen Dungan and Krishna, {Somashekar G.} and Kathleen Wyne and Bellin, {Melena D.} and Dhiraj Yadav and Andersen, {Dana K.} and Jose Serrano and Papachristou, {Georgios I.}",

note = "Funding Information: Research reported in this publication was supported by the National Cancer Institute and National Institute of Diabetes and Digestive and Kidney Diseases under award numbers U01DK127388 (PAH, DB, DLC, KD, GIP), U01DK108327 (PAH, DB, DLC), U01DK126300 (MDB), U01DK127367 (MDB), U01DK108306 (DY), and U01DK127377 (DY). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Publisher Copyright: {\textcopyright} 2021 Elsevier Ltd",

year = "2021",

month = aug,

doi = "10.1016/S2468-1253(21)00019-4",

language = "English (US)",

volume = "6",

pages = "668--675",

journal = "The Lancet Gastroenterology and Hepatology",

issn = "2468-1253",

publisher = "Elsevier Limited",

number = "8",

}

TY - JOUR

T1 - Diabetes following acute pancreatitis

AU - Hart, Phil A.

AU - Bradley, David

AU - Conwell, Darwin L.

AU - Dungan, Kathleen

AU - Krishna, Somashekar G.

AU - Wyne, Kathleen

AU - Bellin, Melena D.

AU - Yadav, Dhiraj

AU - Andersen, Dana K.

AU - Serrano, Jose

AU - Papachristou, Georgios I.

N1 - Funding Information: Research reported in this publication was supported by the National Cancer Institute and National Institute of Diabetes and Digestive and Kidney Diseases under award numbers U01DK127388 (PAH, DB, DLC, KD, GIP), U01DK108327 (PAH, DB, DLC), U01DK126300 (MDB), U01DK127367 (MDB), U01DK108306 (DY), and U01DK127377 (DY). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Publisher Copyright: © 2021 Elsevier Ltd

PY - 2021/8

Y1 - 2021/8

N2 - Diabetes represents a group of diseases involving persistent hyperglycaemia. Exocrine disorders of the pancreas are increasingly recognised to cause or precede the onset of diabetes, which in this context is referred to as pancreatogenic or type 3c diabetes. Diabetes, as a sequela of acute pancreatitis, is observed across the spectrum of severity in acute pancreatitis and can be associated with other clinical complications. The pathophysiology of acute pancreatitis-related diabetes is poorly understood, and observations suggest that it is probably multifactorial. In this Review, we discuss the epidemiology, pathophysiology, and management considerations of diabetes following acute pancreatitis, and highlight knowledge gaps in this topic.

AB - Diabetes represents a group of diseases involving persistent hyperglycaemia. Exocrine disorders of the pancreas are increasingly recognised to cause or precede the onset of diabetes, which in this context is referred to as pancreatogenic or type 3c diabetes. Diabetes, as a sequela of acute pancreatitis, is observed across the spectrum of severity in acute pancreatitis and can be associated with other clinical complications. The pathophysiology of acute pancreatitis-related diabetes is poorly understood, and observations suggest that it is probably multifactorial. In this Review, we discuss the epidemiology, pathophysiology, and management considerations of diabetes following acute pancreatitis, and highlight knowledge gaps in this topic.

UR - http://www.scopus.com/inward/record.url?scp=85109446721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85109446721&partnerID=8YFLogxK

U2 - 10.1016/S2468-1253(21)00019-4

DO - 10.1016/S2468-1253(21)00019-4

M3 - Review article

C2 - 34089654

AN - SCOPUS:85109446721

SN - 2468-1253

VL - 6

SP - 668

EP - 675

JO - The Lancet Gastroenterology and Hepatology

JF - The Lancet Gastroenterology and Hepatology

IS - 8

ER -

Diabetes following acute pancreatitis

Abstract

Bibliographical note

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this